Abstracts trials mixed these types in different (and even unstated) proportions. Some (n = 12) required sinus rhythm for various durations at randomization, increasing the chance of success; 4 ignored early recurrences or allowed for recardioversion, while 16 counted every recurrence. In addition, methods used to detect recurrence varied from ECG confirmation at regularly scheduled visits to much more sensitive trans-telephonic monitoring (n = 11), which was employed in differing ways. Furthermore, efficacy endpoints were affected by biased termination of follow-up, as treatment withdrawal due to side effects leads to less detection of recurrence. Nevertheless, a published meta-analysis ignored these differences, citing similar recurrence rates in control groups and chi-squared tests that did not detect statistical heterogeneity. In our opinion, this does not adequately address heterogeneity in study designs, and the resulting estimates are unsuitable for economic modeling. CONCLUSION: Strict adherence to frequentist views can lead to inappropriate pooling of trial data and erroneous inputs for economic models. A Bayesian perspective provides a more correct view of the intractable study design differences. The BPSZ-BLISS study is a naturalistic study to evaluate the effectiveness of the BPSZ program by utilizing a sub-set of the Program participants and measuring the following: blood pressure (BP) control, compliance, persistence and treatment satisfaction. METHODS: 20,000 MDs enrolled in the BPSZ Success Zone program were invited to participate in the study. Using an Interactive Voice Response System (IVRS), MDs report BP and other data at the enrollment visit and at every usual care visit up to 12 +/−2 months; subjects self-report BPs, persistence, compliance and treatment satisfaction at 3, 6 and 12 months post BPSZ enrollment. MDs and subjects are supported by call center representatives as needed. In addition to BPSZ program enrollment medication, MDs prescribe anti-hypertensive medications and schedule visits as per usual care. The General Electric Health care database will be used as an external referent to facilitate interpretation of study outcomes. RESULTS: After 12 months, 2,000 IRB approved MDs have enrolled over 10,000 subjects (48% male; mean age 56 years; 26% newly diagnosed); 97% of MDs, and 75% of subjects successfully entered IVRS enrollment data. Automated IVRS validations have successfully maintained cohort integrity and data quality (less than 5% error on key study variables). MD and patient enrollment will continue until April 2007; study completion is scheduled for mid 2008. CON-CLUSION: MD and patient enrollment, and the acquisition of outcomes data in a nationwide health education program require innovative design and automated data management and quality control methodologies. Strengths and weaknesses of the BPSZ-BLISS study design can help inform similar health education program evaluation initiatives. Patients were randomly assigned to receive mobile phone message reminders, postal reminders, and control strategies. To ascertain attendance rates, patients were regularly followed up 12 to 24 weeks after their treatment. Reminders were sent on average at 16 weeks. The primary measure was the attendance rate at 24 weeks. A secondary outcome was identifying the direct cost and benefits of each reminder type. RESULTS: Overall attendance rate was 74.1%. This differed between groups, with 76.1% attendance for the mobile phone messaging group, 73.5% for postal reminders, and 72.4% for the control group. According to a multivariate analysis, the mobile phone messaging group had a significantly higher attendance rate (OR 1.48, 95% CI: 1.01-2.16) than the control group, but the postal reminder group (OR 1.15, 95% CI: 0.79-1.69) did not. Moreover, for one additional visit, the marginal cost of mobile phone messaging (USD 3.1) was much lower than that of postal reminders (USD 47.0). CONCLUSION: Mobile phone messaging is a more cost-effective method to increase the attendance rate at 24 weeks after lipid lowering therapy among hyperlipidemic patients. when study analysis was completed. Subjects had to be 18 years or older, continuously enrolled in the health plan for 2 years, and new users of statin therapy. Members enrolled in any other plan-sponsored IVR initiative were excluded from this analysis. The intervention group received three automated phone calls; call one provided disease state education, call two was a refill reminder, and call three addressed the importance of physician follow up. The program provided customized interaction based on patient response, primary vs. secondary prevention, and refill behavior. Persistence
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